Acitretin in the treatment of severe disorders of keratinization

Peck, 1987, Retinoids, 2582 Marks, 1981, Severe disorders of keratinization; effects of treatment with Tigason (etretinate), Br J Dermatol, 104, 667, 10.1111/j.1365-2133.1981.tb00753.x Tamayo, 1981, Long-term follow-up of 30 children under oral retinoid 10–9359, 287 Orfanos, 1984, Retinoids in clinical dermatology. An update, 314 Dicken, 1984, Retinoids: a review, J Am Acad Dermatol, 11, 541, 10.1016/S0190-9622(84)70204-0 Traupe, 1985, Etretinate therapy in children with severe keratinization defects, Eur J Pediatr, 143, 166, 10.1007/BF00442128 Bollag, 1985, New retinoids with potential use in humans, 289 Parravicini, 1985, Multiple dose pharmacokinetics of Ro 10-1670, the main metabolite of etretinate (Tigason), 289 Brindley, 1989, Overview of recent clinical pharmacokinetic studies with acitretin (Ro 10-1670, etretin), Dermatologica, 178, 79, 10.1159/000248397 Geiger, 1988, Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies, Dermatologica, 176, 182, 10.1159/000248701 Geiger, 1984, Clinical evaluation of an aromatic retinoid Ro-1670 in severe psoriasis, Curr Ther Res, 35, 735 Kingstone, 1987, Etretin therapy for severe psoriasis, Arch Dermatol, 123, 55, 10.1001/archderm.1987.01660250061018 Olsen, 1989, A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis, J Am Acad Dermatol, 21, 681, 10.1016/S0190-9622(89)70236-X Kragballe, 1989, A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study, Acta Derm Venereol (Stockh), 69, 35 Burge, 1985, Diffuse hyperostosis associated with etretinate, Lancet, 11, 397, 10.1016/S0140-6736(85)92546-2 DiGiovanna, 1986, Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate, N Engl J Med, 315, 1177, 10.1056/NEJM198611063151901 Kilcoyne, 1988, Effects of retinoids in bone, J Am Acad Dermatol, 19, 212, 10.1016/S0190-9622(88)70167-X